{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:54:03Z","timestamp":1771001643713,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T00:00:00Z","timestamp":1260489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000594","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T23:03:52Z","timestamp":1260486232000},"page":"e1000594","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":99,"title":["Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR"],"prefix":"10.1371","volume":"5","author":[{"given":"Sean","family":"Ekins","sequence":"first","affiliation":[]},{"given":"Sandhya","family":"Kortagere","sequence":"additional","affiliation":[]},{"given":"Manisha","family":"Iyer","sequence":"additional","affiliation":[]},{"given":"Erica J.","family":"Reschly","sequence":"additional","affiliation":[]},{"given":"Markus A.","family":"Lill","sequence":"additional","affiliation":[]},{"given":"Matthew R.","family":"Redinbo","sequence":"additional","affiliation":[]},{"given":"Matthew D.","family":"Krasowski","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1359-6446(03)03008-3","article-title":"Predicting undesirable drug interactions with promiscuous proteins in silico.","volume":"9","author":"S Ekins","year":"2004","journal-title":"Drug Discovery Today"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1021\/pr8003024","article-title":"Intrinsic disorder in nuclear hormone receptors.","volume":"7","author":"MD Krasowski","year":"2008","journal-title":"J Proteome Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1021\/bi012159+","article-title":"Intrinsic disorder and protein function.","volume":"41","author":"AK Dunker","year":"2002","journal-title":"Biochemistry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.","volume":"95","author":"G Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1101\/gad.12.20.3195","article-title":"SXR, a novel steroid and xenobiotic-sensing nuclear receptor.","volume":"12","author":"B Blumberg","year":"1998","journal-title":"Genes Dev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway.","volume":"92","author":"SA Kliewer","year":"1998","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2407-9-3","article-title":"Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells.","volume":"9","author":"S Verma","year":"2009","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1158\/1078-0432.CCR-08-1033","article-title":"Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer.","volume":"14","author":"D Gupta","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/me.2007-0197","article-title":"The antiapoptotic role of pregnane X receptor in human colon cancer cells.","volume":"22","author":"J Zhou","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11095-009-9901-7","article-title":"Elucidating the \u2018Jekyll and Hyde\u2019 nature of PXR: The case for discovering antagonists.","volume":"26","author":"A Biswas","year":"2009","journal-title":"Pharm Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0091270007299930","article-title":"Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.","volume":"47","author":"BL Urquhart","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref12","article-title":"Elucidating the \u2018Jekyll and Hyde\u2019 Nature of PXR: The Case for Discovering Antagonists Pharm Res Submitted.","author":"S Mani","year":"2009"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/tx800102e","article-title":"Machine learning methods and docking for predicting human pregnane X receptor activation.","volume":"21","author":"A Khandelwal","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-2836(03)00795-2","article-title":"Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor.","volume":"331","author":"RE Watkins","year":"2003","journal-title":"J Mol Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/bi0268753","article-title":"2.1A crystal structure of human PXR in complex with the St John's Wort compound hyperforin.","volume":"42","author":"RE Watkins","year":"2003","journal-title":"Biochemistry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmc.2006.12.026","article-title":"Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.","volume":"15","author":"Y Xue","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/me.2004-0346","article-title":"Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.","volume":"19","author":"JE Chrencik","year":"2005","journal-title":"Mol Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1124\/mol.108.050732","article-title":"Structural basis of human pregnane X receptor activation by the hops constituent colupulone.","volume":"74","author":"DG Teotico","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/me.2006-0323","article-title":"Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition.","volume":"21","author":"Y Xue","year":"2007","journal-title":"Mol Endocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1021\/jp980230o","article-title":"Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods.","volume":"102","author":"AK Ghose","year":"1998","journal-title":"J Phys Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.","volume":"292","author":"RE Watkins","year":"2001","journal-title":"Science"},{"key":"ref22","article-title":"Hybrid scoring and classification approaches to predict human pregane X receptor activiators.","author":"S Kortagere","year":"2008","journal-title":"Pharm Res In press"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1023\/A:1021429105173","article-title":"A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRa and LXRb.","volume":"19","author":"S Ekins","year":"2002","journal-title":"Pharm Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tox.2004.06.036","article-title":"In silico tools to aid risk assessment of endocrine disrupting chemicals.","volume":"205","author":"MN Jacobs","year":"2004","journal-title":"Toxicology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/dmd.105.008458","article-title":"A Combined Approach to Drug Metabolism and Toxicity Assessment.","volume":"34","author":"S Ekins","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2004.03.005","article-title":"PXR and the regulation of apoA1 and HDL-cholesterol in rodents.","volume":"50","author":"K Bachmann","year":"2004","journal-title":"Pharmacol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/mol.107.038398","article-title":"Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites.","volume":"72","author":"S Ekins","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A pharmacophore for human pregnane-X-receptor ligands.","volume":"30","author":"S Ekins","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/ci049722q","article-title":"The identification of ligand features essential for PXR activation by pharmacophore modeling.","volume":"45","author":"D Schuster","year":"2005","journal-title":"J Chem Inf Model"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.106.027623","article-title":"In silico prediction of pregnane X receptor activators by machine learning approaches.","volume":"71","author":"CY Ung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2148-8-103","article-title":"Evolution of pharmacologic specificity in the pregnane X receptor.","volume":"8","author":"S Ekins","year":"2008","journal-title":"BMC Evol Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.","volume":"110","author":"RD Cramer","year":"1988","journal-title":"J Am Chem Soc"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1023\/B:PHAM.0000003377.39548.f6","article-title":"Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.","volume":"20","author":"CR Yates","year":"2003","journal-title":"Pharm Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cmdc.200700036","article-title":"Modeling promiscuity based on in vitro safety pharmacology profiling data.","volume":"2","author":"K Azzaoui","year":"2007","journal-title":"ChemMedChem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1124\/dmd.108.020701","article-title":"A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine.","volume":"36","author":"K Yasuda","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2006.11.016","article-title":"Estrogens and antiestrogens activate PXR.","volume":"170","author":"W Mnif","year":"2007","journal-title":"Toxicol Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11030-006-9041-5","article-title":"Cheminformatics analysis and learning in a data pipelining environment.","volume":"10","author":"M Hassan","year":"2006","journal-title":"Mol Divers"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00498250601050412","article-title":"Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach.","volume":"37","author":"YD Gao","year":"2007","journal-title":"Xenobiotica"},{"key":"ref39","article-title":"The PyMOL Molecular Graphics System","author":"WL DeLano","year":"2002"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1021\/jm049687e","article-title":"Raptor: combining dual-shell representation, induced-fit simulation, and hydrophobicity scoring in receptor modeling: application toward the simulation of structurally diverse ligand sets.","volume":"47","author":"MA Lill","year":"2004","journal-title":"J Med Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1000111","DOI":"10.1371\/journal.pcbi.1000111","article-title":"Active nuclear receptors exhibit highly correlated AF-2 domain motions.","volume":"4","author":"DG Teotico","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/1087057105281365","article-title":"Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.","volume":"10","author":"D Rogers","year":"2005","journal-title":"J Biomol Screen"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/ci800143n","article-title":"Global Bayesian models for the prioritization of antitubercular agents.","volume":"48","author":"P Prathipati","year":"2008","journal-title":"J Chem Inf Model"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10822-007-9109-z","article-title":"Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups.","volume":"21","author":"JT Metz","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/cmdc.200700026","article-title":"Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure.","volume":"2","author":"A Bender","year":"2007","journal-title":"ChemMedChem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/ci060003g","article-title":"Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.","volume":"46","author":"Nidhi","year":"2006","journal-title":"J Chem Inf Model"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11095-008-9809-7","article-title":"Hybrid scoring and classification approaches to predict human pregane X receptor activiators.","volume":"26","author":"S Kortagere","year":"2009","journal-title":"Pharm Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.drudis.2006.06.013","article-title":"Can we estimate the accuracy of ADME-Tox predictions?","volume":"11","author":"IV Tetko","year":"2006","journal-title":"Drug Discov Today"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/ci800151m","article-title":"Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.","volume":"48","author":"IV Tetko","year":"2008","journal-title":"J Chem Inf Model"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/jcc.20981","article-title":"Pareto optimization in computational protein design with multiple objectives.","volume":"29","author":"M Suarez","year":"2008","journal-title":"J Comput Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cmdc.200500024","article-title":"Prediction of Small-Molecule Binding to Cytochrome P450 3A4: Flexible Docking Combined with Multidimensional QSAR.","volume":"6","author":"MA Lill","year":"2006","journal-title":"ChemMedChem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/ci050427v","article-title":"PharmID: pharmacophore identification using Gibbs sampling.","volume":"46","author":"J Feng","year":"2006","journal-title":"J Chem Inf Model"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tips.2008.12.001","article-title":"The importance of discerning shape in molecular pharmacology.","volume":"30","author":"S Kortagere","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/me.2004-0427","article-title":"Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.","volume":"19","author":"MD Krasowski","year":"2005","journal-title":"Mol Endocrinol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking.","volume":"267","author":"G Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/ci0601315","article-title":"Improved naive Bayesian modeling of numerical data for absorption, distribution, metabolism and excretion (ADME) property prediction.","volume":"46","author":"AE Klon","year":"2006","journal-title":"J Chem Inf Model"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/ci6001944","article-title":"Combining 4D pharmacophore generation and multidimensional QSAR: Modeling ligand binding to the Bradykinin B2 receptor.","volume":"46","author":"MA Lill","year":"2006","journal-title":"J Chem Inf Model"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T06:01:40Z","timestamp":1590300100000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000594"}},"subtitle":[],"editor":[{"given":"James M.","family":"Briggs","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,12,11]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000594","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,11]]}}}